Citadel Advisors »

Vor Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Vor Biopharma shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 25k 48.67

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Vor Biopharma

Susquehanna International
RA Capital Management
Shay Capital
VR Adviser
Fcpm Iii Services B.v.
FMR
Belvedere Trading
Ariose Capital Management
Vanguard Group
UBS Group
Johnson & Johnson
Tang Capital Management
Jane Street
BlackRock
Geode Capital Management

View all funds holding Vor Biopharma